Literature DB >> 1420046

Laser trabeculoplasty.

R Coakes1.   

Abstract

Using the now well established technique ALT is a safe and effective means of lowering IOP in eyes with POAG, pigmentary glaucoma, and exfoliative glaucoma though the effect diminishes with time. Pressure reduction with ALT is seldom greater than 30% and eyes with an IOP of more than 28 mm Hg are unlikely to be controlled for any length of time without additional treatment. ALT is probably most suitable either for older patients whose glaucoma is not well controlled on medical treatment, or for patients with newly diagnosed open angle glaucoma, but without advanced field loss, as a primary treatment or in combination with a non-miotic topical medication. In many it will defer surgery, in some indefinitely.

Entities:  

Mesh:

Year:  1992        PMID: 1420046      PMCID: PMC505241          DOI: 10.1136/bjo.76.10.624

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  36 in total

1.  Diurnal intraocular pressure after successful primary laser trabeculoplasty.

Authors:  T Elsås; H Junk; H Johnsen
Journal:  Am J Ophthalmol       Date:  1991-07-15       Impact factor: 5.258

2.  Trabecular cell division after argon laser trabeculoplasty.

Authors:  S S Bylsma; J R Samples; T S Acott; E M Van Buskirk
Journal:  Arch Ophthalmol       Date:  1988-04

3.  The prediction of intraocular pressure rise following argon laser trabeculoplasty.

Authors:  S J Keightley; P T Khaw; A R Elkington
Journal:  Eye (Lond)       Date:  1987       Impact factor: 3.775

4.  Laser power and postoperative intraocular pressure increase in argon laser trabeculoplasty.

Authors:  H J Rouhiainen; M E Teräsvirta; E J Tuovinen
Journal:  Arch Ophthalmol       Date:  1987-10

5.  Primary lasertrabeculoplasty a comparison of 50 spots in 180 degrees and 100 spots in 360 degrees of the trabecular meshwork.

Authors:  T Elsås
Journal:  Acta Ophthalmol (Copenh)       Date:  1987-06

6.  Retreatment with argon laser trabeculoplasty.

Authors:  C U Richter; B J Shingleton; A R Bellows; B T Hutchinson; L P Jacobson
Journal:  Ophthalmology       Date:  1987-09       Impact factor: 12.079

7.  Control of chronic simple glaucoma with primary medical, surgical and laser treatment.

Authors:  C Migdal; R Hitchings
Journal:  Trans Ophthalmol Soc U K       Date:  1986

8.  Effects of ALO 2145 on intraocular pressure following argon laser trabeculoplasty.

Authors:  A L Robin; I P Pollack; B House; C Enger
Journal:  Arch Ophthalmol       Date:  1987-05

9.  Inflammation patterns after laser trabeculoplasty measured with the laser flare meter.

Authors:  A Mermoud; N Pittet; C P Herbort
Journal:  Arch Ophthalmol       Date:  1992-03

10.  Laser trabeculoplasty as supplementary treatment for primary open angle glaucoma.

Authors:  M B Sherwood; J Lattimer; R A Hitchings
Journal:  Br J Ophthalmol       Date:  1987-03       Impact factor: 4.638

View more
  4 in total

1.  Immediate intraocular pressure response to selective laser trabeculoplasty.

Authors:  P Lanzetta; U Menchini; G Virgili
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

2.  Efficacy of argon laser trabeculoplasty: 3-year preliminary results of a prospective placebo-controlled study.

Authors:  C Ustundag; M Diestelhorst
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

Review 3.  Selective laser trabeculoplasty: past, present, and future.

Authors:  A Garg; G Gazzard
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

Review 4.  A Review of Selective Laser Trabeculoplasty: "The Hype Is Real".

Authors:  Tomislav Sarenac; Anela Bečić Turkanović; Peter Ferme; Tomaž Gračner
Journal:  J Clin Med       Date:  2022-07-04       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.